Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Insulin-like growth factor 1 receptor polymorphism rs2229765 and circulating interleukin-6 level affect male longevity in a population-based prospective study (Treviso Longeva--TRELONG).

Albani D, Mazzuco S, Polito L, Batelli S, Biella G, Ongaro F, Gustafson DR, Antuono P, Gajo G, Durante E, Caberlotto L, Zanardo A, Siculi M, Gallucci M, Forloni G.

Aging Male. 2011 Dec;14(4):257-64. doi: 10.3109/13685538.2011.607521.

PMID:
22115178
2.

A polymorphic variant of the insulin-like growth factor 1 (IGF-1) receptor correlates with male longevity in the Italian population: a genetic study and evaluation of circulating IGF-1 from the "Treviso Longeva (TRELONG)" study.

Albani D, Batelli S, Polito L, Vittori A, Pesaresi M, Gajo GB, De Angeli S, Zanardo A, Gallucci M, Forloni G.

BMC Geriatr. 2009 May 21;9:19. doi: 10.1186/1471-2318-9-19.

3.

The influence of an insulin-like growth factor I gene promoter polymorphism on hip bone geometry and the risk of nonvertebral fracture in the elderly: the Rotterdam Study.

Rivadeneira F, Houwing-Duistermaat JJ, Beck TJ, Janssen JA, Hofman A, Pols HA, Van Duijn CM, Uitterlinden AG.

J Bone Miner Res. 2004 Aug;19(8):1280-90. Epub 2004 Apr 12.

4.

Insulin-like growth factor-1 receptor polymorphism and ischemic stroke: a case-control study in Chinese population.

Cheng J, Liu J, Li X, Peng J, Han S, Zhang R, Xu Y, Nie S.

Acta Neurol Scand. 2008 Nov;118(5):333-8. doi: 10.1111/j.1600-0404.2008.01040.x. Epub 2008 May 9.

PMID:
18477064
5.

A gender--dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity.

Bonafè M, Olivieri F, Cavallone L, Giovagnetti S, Mayegiani F, Cardelli M, Pieri C, Marra M, Antonicelli R, Lisa R, Rizzo MR, Paolisso G, Monti D, Franceschi C.

Eur J Immunol. 2001 Aug;31(8):2357-61.

6.

A polymorphic CA repeat in the IGF-I gene is associated with gender-specific differences in body height, but has no effect on the secular trend in body height.

Rietveld I, Janssen JA, van Rossum EF, Houwing-Duistermaat JJ, Rivadeneira F, Hofman A, Pols HA, van Duijn CM, Lamberts SW.

Clin Endocrinol (Oxf). 2004 Aug;61(2):195-203.

PMID:
15272914
7.

Interleukin 6-174 G/C promoter gene polymorphism in centenarians: no evidence of association with human longevity or interaction with apolipoprotein E alleles.

Capurso C, Solfrizzi V, D'Introno A, Colacicco AM, Capurso SA, Semeraro C, Capurso A, Panza F.

Exp Gerontol. 2004 Jul;39(7):1109-14.

PMID:
15236771
8.

Absence of association between SNPs in the promoter region of the insulin-like growth factor 1 (IGF-1) gene and longevity in the Han Chinese population.

Xie L, Gong YY, Lian SG, Yang J, Yang Y, Gao SJ, Xu LY, Zhang YP.

Exp Gerontol. 2008 Oct;43(10):962-5. doi: 10.1016/j.exger.2008.08.004. Epub 2008 Aug 12.

PMID:
18761080
9.

The IRS2 Gly1057Asp variant is associated with human longevity.

Barbieri M, Rizzo MR, Papa M, Boccardi V, Esposito A, White MF, Paolisso G.

J Gerontol A Biol Sci Med Sci. 2010 Mar;65(3):282-6. doi: 10.1093/gerona/glp154. Epub 2009 Nov 3.

PMID:
19887537
10.

Gender-specific association between -1082 IL-10 promoter polymorphism and longevity.

Lio D, Scola L, Crivello A, Colonna-Romano G, Candore G, Bonafè M, Cavallone L, Franceschi C, Caruso C.

Genes Immun. 2002 Feb;3(1):30-3.

11.

Association of +3179G/A insulin-like growth factor-1 receptor polymorphism and insulin-like growth factor-1 serum level with systemic lupus erythematosus.

Stanilova SA, Ivanova MG, Karakolev IA, Stoilov RM, Rashkov RK, Manolova IM.

Lupus. 2013 Nov;22(13):1388-93. doi: 10.1177/0961203313502860. Epub 2013 Aug 29.

PMID:
23989734
12.

Associations of the plasma interleukin 6 (IL-6) levels with disability and mortality in the elderly in the Treviso Longeva (Trelong) study.

Gallucci M, Amici GP, Ongaro F, Gajo GB, De Angeli S, Forloni GL, Albani D, Prato F, Polito L, Zanardo A, Regini C.

Arch Gerontol Geriatr. 2007;44 Suppl 1:193-8.

PMID:
17317452
13.

Interleukin-6 plasma level increases with age in an Italian elderly population ("The Treviso Longeva"-Trelong-study) with a sex-specific contribution of rs1800795 polymorphism.

Albani D, Batelli S, Polito L, Prato F, Pesaresi M, Gajo GB, De Angeli S, Zanardo A, Galimberti D, Scarpini E, Gallucci M, Forloni G.

Age (Dordr). 2009 Jun;31(2):155-62. doi: 10.1007/s11357-009-9092-5. Epub 2009 Apr 18.

14.

Reduced insulin/IGF-1 signalling and human longevity.

van Heemst D, Beekman M, Mooijaart SP, Heijmans BT, Brandt BW, Zwaan BJ, Slagboom PE, Westendorp RG.

Aging Cell. 2005 Apr;4(2):79-85.

15.
16.

Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women.

Jernström H, Deal C, Wilkin F, Chu W, Tao Y, Majeed N, Hudson T, Narod SA, Pollak M.

Cancer Epidemiol Biomarkers Prev. 2001 Apr;10(4):377-84.

17.

The relationship in Japanese infants between a genetic polymorphism in the promoter region of the insulin-like growth factor I gene and the plasma level.

Kinoshita Y, Kizaki Z, Ishihara Y, Nakajima H, Adachi S, Kosaka K, Kinugasa A, Sugimoto T.

Neonatology. 2007;92(2):116-9. Epub 2007 Mar 23.

PMID:
17377412
18.

Relationship of insulin-like growth factors system gene polymorphisms with the susceptibility and pathological development of hepatocellular carcinoma.

Weng CJ, Hsieh YH, Tsai CM, Chu YH, Ueng KC, Liu YF, Yeh YH, Su SC, Chen YC, Chen MK, Yang SF.

Ann Surg Oncol. 2010 Jul;17(7):1808-15. doi: 10.1245/s10434-009-0904-8. Epub 2010 Jan 30.

PMID:
20119675
19.

Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.

Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Cantini F, Macchioni P, Bajocchi G, Catanoso MG, Pulsatelli L, Consonni D, Salvarani C.

J Rheumatol. 2006 Apr;33(4):703-8.

PMID:
16583473

Supplemental Content

Support Center